Autoimmune Hemolytic Anemia as the Herald State of Hodgkin's Disease

Abstract
Anemia is a common manifestation of Hodgkin's disease; Levinson, Walter, Wintrobe, and Cartwright (1) found mild or moderate anemia in 52% of patients before therapy and showed that moderate anemia, while not necessarily a late manifestation of the disease, was usually associated with short survival and a poor prognosis. Such anemia has been shown to be the result of the shortening of the survival time of the red cells together with an inadequate erythropoietic response so that the bone marrow is unable to compensate for the increased rate of red cell destruction (2). Frankly hemolytic anemia has also been described